These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23874743)

  • 1. Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance.
    Dowling NM; Gleason CE; Manson JE; Hodis HN; Miller VM; Brinton EA; Neal-Perry G; Santoro MN; Cedars M; Lobo R; Merriam GR; Wharton W; Naftolin F; Taylor H; Harman SM; Asthana S
    PLoS One; 2013; 8(7):e68741. PubMed ID: 23874743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.
    Gleason CE; Dowling NM; Wharton W; Manson JE; Miller VM; Atwood CS; Brinton EA; Cedars MI; Lobo RA; Merriam GR; Neal-Perry G; Santoro NF; Taylor HS; Black DM; Budoff MJ; Hodis HN; Naftolin F; Harman SM; Asthana S
    PLoS Med; 2015 Jun; 12(6):e1001833; discussion e1001833. PubMed ID: 26035291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: A cross-sectional study.
    Jin X; He W; Zhang Y; Gong E; Niu Z; Ji J; Li Y; Zeng Y; Yan LL
    PLoS Med; 2021 Jun; 18(6):e1003597. PubMed ID: 34061824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer.
    Koleck TA; Bender CM; Sereika SM; Ahrendt G; Jankowitz RC; McGuire KP; Ryan CM; Conley YP
    Oncol Nurs Forum; 2014 Nov; 41(6):E313-25. PubMed ID: 25355028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women.
    Steffens DC; Norton MC; Plassman BL; Tschanz JT; Wyse BW; Welsh-Bohmer KA; Anthony JC; Breitner JC
    J Am Geriatr Soc; 1999 Oct; 47(10):1171-5. PubMed ID: 10522948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline.
    Bangen KJ; Beiser A; Delano-Wood L; Nation DA; Lamar M; Libon DJ; Bondi MW; Seshadri S; Wolf PA; Au R
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1361-9. PubMed ID: 23601373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study.
    DeCarli C; Reed T; Miller BL; Wolf PA; Swan GE; Carmelli D
    Stroke; 1999 Aug; 30(8):1548-53. PubMed ID: 10436099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.
    Gharbi-Meliani A; Dugravot A; Sabia S; Regy M; Fayosse A; Schnitzler A; Kivimäki M; Singh-Manoux A; Dumurgier J
    Alzheimers Res Ther; 2021 Jan; 13(1):5. PubMed ID: 33397450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term, low-dose sex hormone replacement therapy on hippocampus and cognition of postmenopausal women of different apoE genotypes.
    Yue Y; Hu L; Tian QJ; Jiang JM; Dong YL; Jin ZY; Cheng YH; Hong X; Ge QS; Zuo PP
    Acta Pharmacol Sin; 2007 Aug; 28(8):1129-35. PubMed ID: 17640473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
    JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive resilience to apolipoprotein E ε4: contributing factors in black and white older adults.
    Kaup AR; Nettiksimmons J; Harris TB; Sink KM; Satterfield S; Metti AL; Ayonayon HN; Yaffe K;
    JAMA Neurol; 2015 Mar; 72(3):340-8. PubMed ID: 25599330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression, cognition, apolipoprotein e genotype: latent class approach to identifying subtype.
    Bogner HR; Richie MB; de Vries HF; Morales KH
    Am J Geriatr Psychiatry; 2009 Apr; 17(4):344-52. PubMed ID: 19307863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone therapy for sexual function in perimenopausal and postmenopausal women.
    Nastri CO; Lara LA; Ferriani RA; Rosa-E-Silva AC; Figueiredo JB; Martins WP
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009672. PubMed ID: 23737033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects.
    Tervo S; Kivipelto M; Hänninen T; Vanhanen M; Hallikainen M; Mannermaa A; Soininen H
    Dement Geriatr Cogn Disord; 2004; 17(3):196-203. PubMed ID: 14739544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the apolipoprotein E genotype with memory performance and executive functioning in cognitively intact elderly.
    Luck T; Then FS; Luppa M; Schroeter ML; Arélin K; Burkhardt R; Thiery J; Löffler M; Villringer A; Riedel-Heller SG
    Neuropsychology; 2015 May; 29(3):382-387. PubMed ID: 25365563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Heterogeneity in Cognitive Function: APOE-e4, Sex, Education, Depression, and Vascular Risk.
    MacAulay RK; Halpin A; Cohen AS; Calamia M; Boeve A; Zhang L; Brouillette RM; Foil HC; Bruce-Keller A; Keller JN
    Arch Clin Neuropsychol; 2020 Aug; 35(6):660-670. PubMed ID: 32129455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction.
    Yaffe K; Haan M; Byers A; Tangen C; Kuller L
    Neurology; 2000 May; 54(10):1949-54. PubMed ID: 10822435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E4 genotype in combination with poor metabolic profile is associated with reduced cognitive performance in healthy postmenopausal women: implications for late onset Alzheimer's disease.
    Karim R; Koc M; Rettberg JR; Hodis HN; Henderson VW; St John JA; Allayee H; Brinton RD; Mack WJ
    Menopause; 2019 Jan; 26(1):7-15. PubMed ID: 29975287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4.
    Burkhardt MS; Foster JK; Laws SM; Baker LD; Craft S; Gandy SE; Stuckey BG; Clarnette R; Nolan D; Hewson-Bower B; Martins RN
    J Alzheimers Dis; 2004 Jun; 6(3):221-8. PubMed ID: 15201477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.